opendata.bot
Company number
10753028

KANDY THERAPEUTICS LIMITED

Active
✓ Active company on the official register. Next accounts due 30 September 2027.

Company details

South East, England Contains OS data © Crown copyright and database right. Contains Royal Mail data © Royal Mail copyright and database right. Source: Office for National Statistics licensed under the Open Government Licence v.3.0.
Registered name
KANDY THERAPEUTICS LIMITED
Company number
10753028
Registered office
400 SOUTH OAK WAY, READING, RG2 6AD, ENGLAND · 7 other companies at this postcode
Company type
Private Limited Company
Incorporated on
3 May 2017
Status
Active
Age
9 years
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts — next due
30 Sept 2027
Accounts — last made up to
31 Dec 2025
Confirmation statement — next due
07 Jun 2027
Confirmation statement — last
24 May 2026

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

Advent Life Sciences Llp
owns 25–50% of shares · holds 25–50% of voting rights
Notified 14/09/2017
Bayer Global Investments Bv
owns 75–100% of shares · holds 75–100% of voting rights · can appoint and remove directors
Notified 08/09/2020
Dr Michael Keith Trower
owns 75–100% of shares · holds 75–100% of voting rights · can appoint and remove directors
Notified 03/05/2017

Corporate structure

Who controls this company, and who they control in turn

3 controllers Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Bayer Global Investments Bv name only
owns 75–100% of shares · holds 75–100% of votes · can appoint and remove directors Notified 08/09/2020
Corporate owner owns 25–50% of shares · holds 25–50% of votes Control ended 24/08/2018 Controls 30 companies
Dr Michael Keith Trower
born 11/1958 · United Kingdom owns 75–100% of shares · holds 75–100% of votes · can appoint and remove directors Control ended 14/09/2017 Controls 2 companies

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
08/09/2020 Person with significant control added Bayer Global Investments Bv
24/08/2018 Person with significant control ceased Advent Life Sciences Llp
14/09/2017 Person with significant control ceased Dr Michael Keith Trower
14/09/2017 Person with significant control added Advent Life Sciences Llp
03/05/2017 Person with significant control added Dr Michael Keith Trower

Documents for KANDY THERAPEUTICS LIMITED

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

No entry found on the ICO register of fee payers under this name.

Not every organisation has to register — some are exempt. An absent entry is a question to ask, not a finding.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/10753028
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of KANDY THERAPEUTICS LIMITED?
According to the official registry, the company number of KANDY THERAPEUTICS LIMITED is 10753028.
Where is KANDY THERAPEUTICS LIMITED registered?
The registered office is 400 SOUTH OAK WAY, READING, RG2 6AD, ENGLAND.
What is the SIC code of KANDY THERAPEUTICS LIMITED?
The nature of business is recorded under SIC code 72110 — Research and experimental development on biotechnology.
Who controls KANDY THERAPEUTICS LIMITED?
Advent Life Sciences Llp is recorded as a person with significant control, and owns 25–50% of shares, holds 25–50% of voting rights.
When are the next accounts of KANDY THERAPEUTICS LIMITED due?
The next annual accounts are due by 30 September 2027, and the last accounts were made up to 31 December 2025.

About KANDY THERAPEUTICS LIMITED (10753028)

KANDY THERAPEUTICS LIMITED is a private limited company incorporated on 3 May 2017 and registered in the United Kingdom under company number 10753028. Its registered office is at 400 SOUTH OAK WAY, READING, RG2 6AD, ENGLAND. The recorded nature of business is research and experimental development on biotechnology (SIC 72110). The company is currently active , with statutory accounts last made up to 31 December 2025. , and the person with significant control is Advent Life Sciences Llp. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Companies at the same registered office

Research and experimental development on biotechnology across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.